English  |  正體中文  |  简体中文  |  Items with full text/Total items : 26988/38789
Visitors : 2324949      Online Users : 60
RC Version 4.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search
LoginUploadHelpAboutAdminister

Please use this identifier to cite or link to this item: http://ntour.ntou.edu.tw:8080/ir/handle/987654321/30577

Title: 蝦白點症預防及控制 - 病毒入侵抑制物口服運送系統之開發計畫( I )
The Prevention and Control of Wssv: Development of Oral Delivery System for Virus Entry Inhibitor
Authors: 陳歷歷
Contributors: NTOU:Institute of Marine Biology
國立臺灣海洋大學:海洋生物研究所
Date: 2011-01
Issue Date: 2012-04-13T01:07:58Z
Publisher: 行政院國家科學委員會
Abstract: 摘要:白點症病毒是造成台灣以及世界其他地區養殖蝦類嚴重死亡的病原體,儘管目前在白點症病毒 的基因體和蛋白質體學方面的研究相當多,然而對於如何預防及控制此病毒仍無具體策略。在過去 的研究中,我們利用酵母菌雙雜合法篩選能與白點症病毒封套蛋白VP53A 結合的蛋白質,發現草蝦 幾丁質結合蛋白能與之結合,並驗證確定草蝦幾丁質結合蛋白位在細胞膜上,分子量約為34 kDa。 我們利用重組VP53A 和幾丁質結合蛋白對白蝦進行活體感染阻斷試驗,發現白蝦的死亡率可有效抑 制,但卻無法百分之百預防,可能是運送至蝦體內的重組蛋白遭酵素破壞,顯示穩定的運送系統有 其重要性。最新的研究中中國研究者試圖以枯草桿菌為蛋白質表現載體系統,並直接以表現重組蛋 白後的死菌餵食實驗蝦,發現效果較以大腸桿菌為蛋白質表現載體系統為佳,顯示利用革蘭氏陽性 菌可能較陰性菌具效果。近來人類癌症治療的研究中使用單核球增多性李斯特菌,利用基因工程技 術使此李斯特菌失去致病力卻仍保有其優點,顯示此系統具水產養殖應用之潛力。本計畫將利用已 知的VP53A 和幾丁質結合蛋白結合模式為基礎,利用李斯特菌系統,以建立一有效的口服運送系統。
Abstract:White spot syndrome virus (WSSV) can cause the most serious viral disease of shrimp and has a wide host range among crustaceans. Although researches showed a lot about its genome and structure, the strategies about how to control and prevent this virus were lacking. In the previous study, WSSV envelope protein, VP53A, was identified to interact with Penaeus monodon chitin-binding protein (PmCBP). PmCBP was confirmed to locate on the cell surface of the host cell, and its molecular weight was about 34 kDa. In the in vivo infection blocking assay, both rVP53A and rPmCBP that were produced by Esherichia coli can promote the survival rate of the shrimp which were challenged by WSSV. The neutralization of both rVP53A and rPmCBP significantly, but incompletely, blocked the WSSV infection. This may due to protein degradation without any protection system. In the recent study using Bacillus subtilis as protein production and delivery material showed the better protection activity then using E. coli. It indicated that Gram+ bacteria may be a better protein production and delivery material then Gram- bacteria. Recently, Listeria monocytogenes was applied to human cancer treatment. The pathogenicity of L. monocytogenes was deleted and this system could be attempted to aqualculture. In this study, we plan to develop an effective oral delivery system based on protein-protein interaction between rVP53A and rPmCBP and the newly application of L. monocytogenes. We hope the study can ultimately help to develop the most efficient anti-viral strategy against WSSV.
Relation: NSC100-2324-B019-002-CC2
URI: http://ntour.ntou.edu.tw/handle/987654321/30577
Appears in Collections:[海洋生物研究所] 研究計畫

Files in This Item:

There are no files associated with this item.



All items in NTOUR are protected by copyright, with all rights reserved.

 


著作權政策宣告: 本網站之內容為國立臺灣海洋大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,請合理使用本網站之內容,以尊重著作權人之權益。
網站維護: 海大圖資處 圖書系統組
DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback